Cleared Traditional

K864338 - SECONDARY SET LOCK

K864338 is an FDA 510(k) clearance for SECONDARY SET LOCK, manufactured by Travenol Laboratories, S.A.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 15-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1986
Decision
15d
Days
Class 2
Risk

K864338 is an FDA 510(k) clearance for the SECONDARY SET LOCK. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Travenol Laboratories, S.A. (Deerfield, US). The FDA issued a Cleared decision on November 19, 1986 after a review of 15 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Travenol Laboratories, S.A. devices

FDA 510(k) Submission Details - K864338

510(k) Number K864338 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 04, 1986
Decision Date November 19, 1986
Days to Decision 15 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
114d faster than avg
Panel avg: 129d · This submission: 15d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 772
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K864338.
NORFOLK MEDICAL BUTTERFLY INFUSION SET
K870188 · Norfolk Medical Products, Inc. · Feb 1987
MANAN CONTRAST MEDIA ADMINISTRATION SET
K864405 · Manan Manufacturing Co., Inc. · Dec 1986
CRIS ADAPTED WITH VOLUME LIMITING BAG
K864164 · Y · Dec 1986
BAG SPIKE EXTENSION SET
K863814 · Med Fusion Systems, Inc. · Oct 1986
EXEL BUTTERFLY SCALP VEIN SET
K862491 · Exel Intl. · Aug 1986
LUER LOCK ADAPTER/NUT
K862653 · Mallinckrodt Critical Care · Jul 1986